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Chronic myeloid leukemia (CML) is a clonal myeloproliferative disease that shows apoptosis resistance. 
The introduction of imatinib mesylate has revolutionized the treatment of CML, but imatinib resistance 
may develop at any time and inevitably leads to disease progression. Synadenium umbellatum Pax. belongs 
to the Euphorbiaceae family and is popularly used in Brazil for the treatment of cancer. The cytotoxicity 
of Euphorbiaceae is associated with the ability of these plants and their bioactive compounds to induce 
apoptotic tumor cell death. Therefore, we aimed to investigate the cytotoxicity and the mechanisms of 
death induced by S. umbellatum extract in leukemic cells. S. umbellatum cytotoxicity was evaluated by 
trypan blue exclusion assay and flow cytometric analysis of the cell cycle; the mechanisms involved in 
K-562 cell death were investigated by light microscopy and flow cytometry. The results demonstrate that 
S. umbellatum is cytotoxic to leukemic cells in a concentration-dependent manner. Morphological analysis 
revealed that S. umbellatum treatment induced K-562 cell death by an apoptotic pathway. Furthermore, 
data indicate ROS overproduction, alterations in mitochondrial membrane potential, phosphatidylserine 
externalization and activation of caspase 9. Taken together, the results demonstrate that S. umbellatum 
extract arrested the cell cycle and triggered apoptosis at several levels in K-562 cells. 
Uniterms: Synadenium umbellatum/pharmacognosy. Synadenium umbellatum/cytotoxicity/evaluation. 
K-562 cells/apoptosis. K-562 cells/cycle arrest. 
A leucemia mielóide crônica (LMC) é uma doença mieloproliferativa clonal, que apresenta resistência à 
apoptose. A introdução do mesilato de imatinibe revolucionou o tratamento da LMC, porém a resistência 
ao imatinibe pode ser desenvolvida em qualquer tempo e, inevitavelmente, leva à progressão da doença. 
Synadenium umbellatum Pax. pertence à família Euphorbiaceae e é usado popularmente no Brasil para 
o tratamento do câncer. A citotoxicidade das Euphorbiaceae está associada com a capacidade dessas 
plantas e seus compostos bioativos em induzir apoptose em células tumorais. Portanto, este trabalho 
teve como objetivo investigar a citotoxicidade e os mecanismos de morte induzidos por S. umbellatum 
em células leucêmicas. A citotoxicidade de S. umbellatum foi avaliada pelo ensaio de exclusão do azul 
de tripano e a análise do ciclo celular foi feita por citometria de fluxo. Os mecanismos envolvidos na 
morte celular das células K-562 foram investigados por microscopia óptica e por citometria de fluxo. 
Os resultados demonstraram que S. umbellatum é citotóxico para células leucêmicas de uma maneira 
dependente da concentração. A análise morfológica revelou que o tratamento com S. umbellatum induziu 
as célula K-562 à morte por via apoptótica. Além disso, os dados indicam aumento de EROS, alterações 
no potencial de membrana mitocondrial, externalização da fosfatidilserina e ativação de caspase 9. Em 
conjunto, os resultados demonstram que S. umbellatum promoveu retenção do ciclo celular das células 
K-562 e induziu estas células à morte por apoptose.
Unitermos: Synadenium umbellatum/farmacognosia. Synadenium umbellatum/citotoxicidade/avaliação. 
Célula K-562/apoptose. Célula K-562/retenção do ciclo.
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INTRODUCTION
Chronic myeloid leukemia (CML) is a clonal my-
eloproliferative disease driven by the BCR-ABL fusion 
protein that arises from the translocation of chromosomes 
9 and 22. This oncoprotein exhibits constitutively active 
kinase activity that confers growth potential and apopto-
sis resistance to CML cells (Cortez, Kadlec, Pendergast, 
1995). BCR-ABL promotes cell division and blocks 
apoptosis, leading to unregulated growth of hematopoietic 
stem cells. Usually, patients with no chemotherapeutic 
treatment progress after several years from a chronic phase 
to a blast crisis, which can rapidly lead to death (O’Hare, 
Corbin, Druker, 2006).
The introduction of imatinib mesylate (Glivec/
Gleevec; Novartis Pharmaceuticals), a tyrosine kinase 
inhibitor, has revolutionized the treatment of CML. Ima-
tinib is widely accepted as the standard of care for the 
first-line treatment of CML, due to its well-documented 
clinical activity, resulting in durable responses and pro-
longed survival. Moreover, toxicities associated with this 
therapy are considered low, and the main toxicities are 
myelosuppression, edema, and myalgia/arthralgia. On 
the other hand, imatinib resistance may develop at any 
time and inevitably leads to disease progression (Fausel, 
2007). In this context, new agents are required for the 
treatment of CML.
Synadenium umbellatum Pax., a species of Euphor-
biaceae widely found in South America, is popularly used 
in Brazil for the treatment of cancer. Studies performed 
by our group demonstrated scientific evidence for the ef-
fectiveness of S. umbellatum extract as an antitumor and 
antiangiogenic agent in vivo using the experimental model 
of Ehrlich ascitic tumor (EAT) (Nogueira et al., 2008). Re-
cently, we also demonstrated the mechanisms of EAT cell 
death induced by S. umbellatum, in vitro. The cytotoxic 
effects found in EAT cells were mediated by activation of 
the intrinsic and extrinsic pathways of apoptosis. Further-
more, we determined by HPLC that the main constituents 
of S. umbellatum crude ethanolic extract are flavonoids 
and terpenes (Mota et al., 2012).
It has been reported in the literature that Euphor-
biaceae species are cytotoxic against different tumor cell 
lines, especially K-562 leukemia cells. In most cases, this 
activity is associated with the ability of these plants to in-
duce cell death, mainly by apoptotic mechanisms (Abreu 
et al., 2006; Amirghofran, et al., 2006; Block et al., 2005; 
Fatope et al., 1996; Grymberg et al., 1999; Itokawa et al., 
1989; Kupchan et al., 1976; Kielland et al., 1996; Maciel 
et al., 2000; Morales et al., 2005; Ngamkitidechakul et al., 
2010; Uthaisang et al., 2004).
In the present work, we investigated the cytotoxic 
activity of S. umbellatum in K-562 and Jurkat leukemia 
cell lines. Since K-562 is a BCR-ABL-expressing hu-
man leukemia cell line, with a drug resistance profile, 
the mechanisms of death induced by S. umbellatum were 
investigated in this cell model.
MATERIALS AND METHODS
Reagents
RPMI 1640 medium, fetal bovine serum, strep-
tomycin, penicillin G, propidium iodide, Giemsa dye, 
RNase, DCFH-DA, EDTA, rhodamine 123, and BSA were 
purchased from Sigma-Aldrich (St. Louis, MO, USA). 
Ethanol and trypan blue were obtained from Vetec (Rio 
de Janeiro, RJ, Brazil). Annexin V-FITC, binding buffer 
(TACS Annexin V-FITC apoptosis detection kit), caspase 
substrate 9, DTT, and lysis buffer (protease colorimetric 
assay kit) were acquired from R&D Systems (Minneapo-
lis, MN, USA). All reagents used were of analytical grade.
Synadenium umbellatum Pax
S. umbellatum (17 kg) aerial parts were collected in 
September 2005 in Goiânia, GO, Brazil (787 m altitude; 
16º 40’ 15.5’’ S; 49º 14’ 13.6’’ W). Voucher specimens 
(No. UFG-27160) were deposited in the Herbarium of 
the Universidade Federal de Goiás (Instituto de Ciências 
Biológicas, Goiânia, GO, Brazil). Air-dried ground S. 
umbellatum material (1.3 kg) was exhaustively macerated 
in 95% ethanol (Vetec, RJ, Brazil), and after filtration, the 
extract was dried in a rotary evaporator (MA 120, Marconi, 
SP, Brazil) to dryness under low pressure and temperature 
to obtain 90 g of crude ethanolic extract (6.9% yield).
Cell culture
K-562 and Jurkat cell lines were obtained from the 
American type culture collection (ATCC, Rockville, MD, 
USA) and maintained in RPMI 1640 medium containing 
10% heat-inactivated fetal bovine serum (FBS), 100 mg/mL 
streptomycin, 100 U/mL penicillin G, and 2 mM L-gluta-
mine in a humidified atmosphere of 5% CO2 in air at 37 oC. 
The cells were passaged twice a week and used in the 
exponential growth phase. Cell viability was determined 
by trypan blue exclusion.
Cytotoxicity assay
The viabilities of K-562 and Jurkat cells were evalu-
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ated using the trypan blue exclusion method. The cells 
(1x106 cells/mL) were seeded in 96-well flat microtiter 
plates (Corning, USA) in RPMI 1640 medium supple-
mented with 10% FBS and incubated with or without eight 
concentrations (0.007 – 1 mg/mL) of S. umbellatum extract 
in six replicates for 24 h. The cell suspension and a trypan 
blue solution (0.2% in phosphate buffered saline - PBS) 
were mixed 1:10 and the viability of cells was estimated 
using a hemacytometer (Boeco, Germany). Stained cells 
were scored as dead. IC50 values (concentration that inhib-
ited cell growth by 50%, compared to untreated controls) 
were determined. For all subsequent assays, a value near 
the IC50 was used.
Light microscopy
The morphological alterations between K-562 cells 
untreated and treated with S. umbellatum were assessed 
by light microscopy. Untreated cells and cells treated with 
0.06 mg/mL S. umbellatum extract were incubated for 24 h 
at 37 oC and 5% CO2 and, after incubation, placed on glass 
slides by cytospin and stained with Giemsa. After stain-
ing, the slides were examined by light microscopy (DM 
2000, Leica microsystems, USA) and images were taken 
using a 40 x objective amplified with 3 x zoom (Canon 
Powershot S80).
Cell cycle analysis
K-562 cells (1x106/mL) were incubated with or 
without 0.06 mg/mL S. umbellatum extract for 24 h. After 
incubation, the cells were washed with ice-cold PBS-
EDTA, centrifuged at 296.82 g for 10 min and fixed with 
2 mL 70% ice-cold ethanol at 4 oC for 24 h. After fixation, 
cells were washed again, resuspended in 500 µL PBS 
solution containing 0.2 mg/mL RNAse and 0.05 mg/mL 
propidium iodide (PI), and then incubated at 4 oC for 2 h. 
Fluorescence was measured with a FACSCanto II flow 
cytometer, using PE x FL2 channels. The assay was car-
ried out in triplicate and 10,000 events were analyzed per 
experiment using the BDFACSDiva software.
Measurement of intracellular ROS
K-562 cells (1x106 /mL) were incubated with or 
without 0.06 mg/mL S. umbellatum extract for 12 and 24 
h. Afterwards, cells were washed with PBS, centrifuged 
at 296.82 g for 10 min and incubated with 500 µL DCFH-
DA (10 µM) for 1 h, and fluorescence determined by flow 
cytometry using the FL1 channel.
Assessment of mitochondrial membrane potential 
(Δψm)
K-562 Cells (1x106/mL), untreated and treated with 
0.06 mg/mL S. umbellatum extract for 24 h, were washed 
with PBS-EDTA, centrifuged at 296.82 g for 10 min, and 
incubated with 1 µg/mL rhodamine 123 at 37 oC for 1 h, 
and the fluorescence determined by flow cytometry, using 
the FL1 channel.
Annexin V-FITC/PI double-staining for 
phosphatidylserine externalization analysis
K-562 Cells (1x106/mL), untreated and treated with 
0.06 mg/mL S. umbellatum extract for 24 h, were washed 
with PBS-BSA and centrifuged at 296.82 g for 10 min. The 
cells were then incubated for 15 min with 100 µL binding 
buffer (10 mmol/L HEPES/NaOH, 140 mmol/L, NaCl 2.5 
mmol/L CaCl2) with 1 µL annexin V-FITC and 10 µL PI 
solution, and analyzed by flow cytometry. Fluorescence 
of annexin V-FITC and PI was measured using the FL1 
and FL2 channels, respectively. 
Caspase activity
The activity of caspase 9 was measured using a 
colorimetric protease assay kit, following the manu-
facturer’s instructions. After 24 h of incubation with or 
without 0.015 mg/mL S. umbellatum extract, K-562 cells 
(1x106/mL) were washed with ice-cold PBS, centrifuged 
at 296.82 g for 10 min and incubated on ice for 20 min 
with 25 µL of cell-lysis buffer (provided in the kit). The 
cell lysate was collected by centrifugation at 29,682.9 g 
at 4 oC for 15 min. The assay was performed in 96 well 
plates containing 50 µL cell lysate, 50 µL 2x reaction buf-
fer, 5 µL caspase colorimetric substrate and 10 µL DTT. 
Duplicate wells were prepared containing blank (no cell 
extract), negative control (extract from untreated cells), 
positive controls (no cell lysate and no substrate) and S. 
umbellatum-treated cells. The plates were incubated at 
37 oC for 2 h, and absorbance was read with a microplate 
reader (Stat Fax 2100, Awareness Technology, Germany) 
at 405 nm. Caspase 9 activity was determined by measur-
ing p-nitroanaline (pNA) released during the cleavage of 
LEHD-pNA substrate.
Statistical analysis
Statistical analysis was performed using Graph Pad 
Prism 5 (version 5.00 for Windows 98, Graph Pad Soft-
ware, San Diego, CA) software. The evaluation of cytotox-
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icity was carried out in three separate experiments. Results 
were converted to percentages of the control and IC50 
values were obtained by non-linear regression analysis. 
Results are expressed as the mean ± SD of six replicates. 
All other assays were analysed by Student’s t-test. Results 
were considered statistically significant when P < 0.05.
RESULTS
Cytotoxic effects of S. umbellatum in leukemic 
cells
S. umbellatum cytotoxicity was evaluated in the 
leukemic cell lines, K-562 and Jurkat, by the trypan 
blue exclusion method, after 24 h of exposure to dif-
ferent concentrations (0.007 - 1 mg/mL). As shown in 
Figure 1, both cell lines studied were highly sensitive 
to S. umbellatum extract, in a concentration-dependent 
manner. Differences in the susceptibility of the two leu-
kemic cell lines to S. umbellatum were observed in the 
IC50 values (IC50 Jurkat = 0.041 mg/mL and IC50 K-562 = 
0.073 mg/mL). Additionally, the effects of S. umbellatum 
on normal lymphocytes from primary culture were stud-
ied; these experiments revealed a high cytotoxic activity 
(data not shown). Based on these findings, the K-562 cell 
line was chosen for subsequent mechanistic studies.
K-562 cell morphology after S. umbellatum 
treatment
Morphological analysis of K-562 cells stained with 
Giemsa revealed alterations after treatment with S. umbel-
latum extract. As can be seen in Figure 2A, control cells 
exhibited nuclei with dispersed chromatin and organized 
plasma membrane. In contrast, cells treated with S. umbel-
latum for 24 h (Figure 2B) showed membrane blebbing 
and chromatin condensation. These microscopic changes, 
caused by S. umbellatum treatment, suggested an activa-
tion of apoptosis. 
Effects of S. umbellatum in cell cycle distribution
Flow cytometric analysis revealed changes in cell 
cycle progression between untreated and treated K-562 
cells (Figures 3A, B). S. umbellatum extract (0.06 mg/mL) 
increased the number of cells in G0/G1 phases by 19.7 ± 
7.9% (P <0.05), followed by a reduction of 74.0 ± 2.4% 
in the S phase (P <0.001) and an increase of 51.2 ± 5.7% 
FIGURE 1 - Cytotoxic effects of Synadenium umbellatum 
extract on K-562 and Jurkat cells after 24 h of treatment 
(0.007–1 mg/mL). The cytotoxic activity was determined by 
trypan blue exclusion assay. Experiments were performed 
in sextuplicate. Each bar presents the mean ± SD of three 
independent experiments. The IC50 was 0.041 mg/mL and 
0.073 mg/mL in Jurkat and K-562 cells, respectively.
FIGURE 2 - Morphological changes of Synadenium umbellatum-induced apoptosis in K-562 cells. Cells were treated with 
0.06 mg/mL Synadenium umbellatum extract for 24 h and images were taken using a 40 x objective amplified with 3 x zoom. 
(A) Control cells stained with Giemsa, showing nuclei with dispersed chromatin and organized plasma membrane (arrow). 
(B) Synadenium umbellatum-treated cells displaying membrane blebbing and chromatin condensation (arrows). Bars: 20 µm.
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in G2 (P <0.01). These results suggest that S. umbellatum 
arrested K-562 cells in the G phases.
S. umbellatum-induced oxidative stress
In addition to cell cycle arrest and morphological 
changes induced by S. umbellatum treatment, a time-
dependent increase in intracellular ROS was found after 
12 and 24 h of incubation with 0.06 mg/mL S. umbel-
latum extract. As shown in Figure 4, the generation of 
ROS dramatically increased with incubation time. Treat-
ment with S. umbellatum for 12 h increased intracellular 
ROS levels by 36.2 ± 13.7%, reaching 111.4% at 24 h 
(P <0.05).
S. umbellatum-induced alterations in 
mitochondrial membrane potential
The most common alteration in Δψm after oxidative 
stress is cellular depolarization, but an early hyperpolariza-
tion can occur. As shown in Figure 5, treatment with 0.06 
mg/mL S. umbellatum extract for 24 h increased Δψm in 
K-562 cells by 117.6 ± 1.9%.
FIGURE 3 - Flow cytometry analysis of K-562 cell cycle with and without treatment with Synadenium umbellatum extract (0.06 
mg/mL) for 24 h. (A) Histograms showing cells untreated and treated with 0.06 mg/mL S. umbellatum for 24 h. (B) Percentage of 
K-562 cells in G1, S and G2 phases with and without S. umbellatum treatment. Each bar represents the mean ± SD of two independent 
experiments (*P < 0.05; **P < 0.01;***P < 0.001).
Phosphatidylserine exposure, induced by 
S. umbellatum
To differentiate cells undergoing apoptosis by PS 
F IGURE 4 -  Effects  of  S.  umbel latum  t reatment  of 
K-562 cells on ROS generation. Cells were treated with 
0.06 mg/mL S. umbellatum extract for 12 and 24 h, incubated 
with 10 µM DCFH-DA for 1 h and analyzed by flow cytometry 
(* P < 0.05 compared to untreated).
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exposure or necrosis by rupture of plasma membrane in S. 
umbellatum-mediated cell death, K-562 cells were labeled 
with annexin V-FITC (A) and PI. As shown in Figure 6, 
after 24 h of treatment with 0.06 mg/mL S. umbellatum 
extract, the number of live cells (A-/PI-) decreased by 16.0 
± 0.8% (P < 0.01), while the number of apoptotic cells 
(A+/PI+) increased by 286.1 ± 30.8% (P <0.001).
Activation of caspase 9 by S. umbellatum
To investigate whether caspases were activated dur-
ing S. umbellatum-induced cell death, a colorimetric assay 
was performed. As shown in Figure 7, after 24 h of expo-
sure to 0.015 mg/mL S. umbellatum, there was a significant 
increase in caspase 9 activity (15.9± 0.4%), as detected 
by cleavage of LEHD-pNA substrate. Thus, induction 
of caspase activity may be involved in S. umbellatum-
induced apoptosis.
DISCUSSION AND CONCLUSION
In the present study, a BCR-ABL-expressing human 
leukemic cell line, K562, was used as a model system of 
resistance to apoptosis induced by conventional chemo-
FIGURE 5 - Effect of Synadenium umbellatum on mitochondrial 
membrane potential (Δψm) of K-562 cells. The graph shows 
rhodamine 123 intensity of untreated cells and cells treated 
with 0.06 mg/mL S. umbellatum extract for 24 h (**P < 0.01). 
FIGURE 6 - Flow cytometry analysis of phosphatidylserine externalization in Synadenium umbellatum-treated K-562 cells. Cells 
were labeled with annexin V-FITC and PI. (A) Untreated cells and cells treated with 0.06 mg/mL S. umbellatum for 24 h. Lower 
left quadrants (A-/PI-) = % of viable cells. Lower right quadrants (A+/PI-) = % of early apoptotic cells. Upper left quadrants 
(A+/PI+) = % of late apoptotic cells. Upper right quadrants (A-/PI+) = % of necrotic cells. (B) Comparison of fluorescence intensity 
of annexin V-FITC and PI between untreated and S. umbellatum-treated cells. The bar represents the mean ± SD of two independent 
experiments (**P < 0.01;***P < 0.001 compared to untreated).
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FIGURE 7 - Activation of caspase 9 during Synadenium 
umbellatum-induced apoptosis. K-562 cells were treated 
with 0.015 mg/mL S. umbellatum extract for 24 h. Kinetics of 
the enzymatic activity of caspase 9 was evaluated. Each bar 
represents the mean ± SD of two independent experiments 
(* P < 0.05 compared to control).
therapeutics to investigate the mechanisms of the antitu-
mor activity found in S. umbellatum. The results presented 
herein showed that S. umbellatum was cytotoxic to hu-
man leukemia cells. The mechanistic investigation using 
K-562 showed that S. umbellatum promoted cell growth 
arrest and induced death via apoptosis by increasing ROS 
production, alterations in mitochondrial functions, PS 
externalization and activation of caspases.
Plant families possessing bioactive compounds, 
particularly terpenes, have shown antitumor properties 
(Mota et al., 2012). The cytotoxic activity of the Euphor-
biaceae has been associated with induction of apoptosis 
in tumor cells. The extract of Croton malambo H. Karst. 
was reported to induce tumor cell apoptosis (Morales et 
al., 2005). In this study, we demonstrated morphological 
and biochemical changes in K-562 cells after S. umbel-
latum treatment, corroborating the reported induction of 
apoptosis by Euphorbia cheiradenia Boiss. & Hohen. in 
K-562 cells (Amirghofran et al., 2006).
For the apoptotic process, a disruption of mito-
chondrial membrane integrity is decisive. An increase in 
ROS production and consequent loss of Δψm are reported 
as typical phenomena in the process of mitochondrial-
mediated apoptosis (Fang et al., 2007). Mitochondrial 
membrane depolarization is a universal event in apoptosis, 
but it has been suggested that the inner membrane of mito-
chondria may undergo a transient hyperpolarization during 
apoptosis (Liu et al., 2005; Matsuyama, Reed, 2000; Poot, 
Pierce, Kavanagh, 2002). Our data revealed an increase 
in ROS levels, followed by an early increase in Δψm (hy-
perpolarization) after S. umbellatum treatment, suggesting 
that apoptosis, induced by S. umbellatum, is mitochondria-
dependent. S. umbellatum-induced apoptosis in K-562 
cells also promoted PS externalization, an event that oc-
curs during the effector phase of apoptosis (Van Engeland 
et al., 1998), as observed for the VR-3848 peptide, isolated 
from a Euphorbiaceae plant, which induced leukemic cells 
to undergo apoptosis through negative modulation of the 
anti-apoptotic protein Bcl-2, nuclear condensation, DNA 
fragmentation, caspase activation and PS externalization 
(Uthaisang et al., 2004).
Caspases play a critical role in the progression of 
apoptosis; activation of caspases takes place via the ex-
trinsic or caspase 8-mediated and the intrinsic or caspase 
9-mediated pathways. Both pathways can converge to 
activate effector caspases, which induce changes charac-
teristic of apoptosis (Datta et al., 2009). In this study, we 
demonstrated that apoptosis, mediated by S. umbellatum, 
involved the activation of caspase 9. This finding suggests 
that S. umbellatum induced apoptosis in K-562 cells by 
the mitochondrial pathway. Corroborating our findings, 
diterpenes isolated from Croton zambesicus Müll. Arg. 
(Euforbiaceae) have also been found to induce apoptosis 
in human leukemic cells by caspase activation (Block et 
al., 2005).
Inhibition of cancer growth has been a continuous 
target in cancer treatment. A reduction in cell growth and 
an induction of cell death are two major mechanisms that 
may be employed to inhibit tumor growth (Zhang et al., 
2009). In this study, we demonstrated that, in addition to 
the induction of leukemic cell death, S. umbellatum also 
promoted an inhibition of the growth of these cells, by a 
cell cycle arrest, increasing the number of cells in G1 and 
G2 in parallel with a reduction in the phase S. In agreement 
with these findings, the anti-proliferative effect of jolkino-
lide B in K-562 cells is reported to result from the arrest 
of the cell cycle in the G0/G1 phase and the subsequent 
induction of apoptosis (Luo, Wang, 2006).
Taken together, our data showed that S. umbella-
tum is cytotoxic to human leukemia cells, promoting cell 
growth inhibition and inducing death via apoptosis by an 
increase in ROS generation, alterations in mitochondrial 
functions, PS externalization and activation of caspase 9. 
Considering the clinical limitations in CML treatment, it is 
clear that new agents with different mechanisms of action 
are desired, both for primary treatment and as adjuvant to 
improve cancer therapy.
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